Axelyf discloses $2.7 million equity offering in SEC Form D filing

Axelyf, Inc., a Delaware corporation incorporated within the last five years, in 2025¹, filed a Form D notice with the SEC dated October 13, 2026. The company is based in Chestnut Hill, Massachusetts¹ and is classified under the biotechnology industry group¹.

The filing lists Orn Almarsson as executive officer, director, and promoter¹ of the company, alongside Leslie Williams and Arni Blondal, who are each listed as directors.

According to the notice, the first sale under this offering occurred on October 7, 2026¹, and the company does not intend for the offering to continue beyond one year. The securities being offered are classified as equity under the filing.

On the question of whether the raise is tied to a merger, acquisition, or exchange offer, the filing answers no.

Financially, Axelyf reported a total offering amount of $2,700,000, with $2,631,439 already sold and $68,561 remaining to be sold¹. The filing notes that approximately $800,000 of founder-related debt and note conversions are included in those sold and offering totals¹. The company reported no sales commissions or finders' fees in connection with the raise, and listed eight investors who have already invested in the offering¹.

The offering was made under Rule 506(b)¹ of Regulation D, a common exemption used by private companies raising capital from accredited investors without public registration. The filing did not disclose the company's revenue range or net asset value, checking "decline to disclose" for that item.